Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge acts for Orexo in connection with its rights offering
Mandate

Vinge acts for Orexo in connection with its rights offering

May 05, 2011

Orexo AB (publ) (NASDAQ OMX Stockholm) has announced an underwritten rights offering with pre-emptive rights for the shareholders and holders of the company’s convertible bonds.

Vinge acts for Orexo. The Vinge team is headed by capital markets partner Erik Sjöman and includes Christian Lindhé, Jakob Warren and Markus Larsson. Dain Nevonen and Maria Doeser are also on the Vinge team.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026